The abstract is read at the publisher; the summary is JClub's.
A recombinant lymphocytic choriomeningitis virus (LCMV) with charge-reversing GPC cytoplasmic mutations (KRR496-498EED) is robustly attenuated in mice and protects against lethal wild-type challenge.
- Why it matters: Canonical karyopherin roles in nuclear transport are well studied, but non-canonical functions in viral infection and release are unclear, limiting rational vaccine design.
- What they did: Using LCMV, the study shows importin-5 (IPO5) recognizes the basic amino acid-rich cytoplasmic domain of the viral glycoprotein (GPC), and disrupting the IPO5-GPC interaction reduces replication.
- The result: The IPO5-GPC disruption attenuates LCMV in vivo and induces potent protective immunity, and IPO5 also affects release of enveloped RNA viruses with basic-residue–enriched glycoprotein cytoplasmic domains.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.